You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs in ATC Class D02B


✉ Email this page to a colleague

« Back to Dashboard


Subclasses in ATC: D02B - PROTECTIVES AGAINST UV-RADIATION

Market Dynamics and Patent Landscape for ATC Class D02B – Protectives Against UV-Radiation

Last updated: January 4, 2026

Summary
The ATC (Anatomical Therapeutic Chemical) Classification System class D02B pertains to materials used as protectives against ultraviolet (UV) radiation, notably in personal care and healthcare products. This sector has experienced significant market evolution driven by rising awareness of UV-related skin health issues, regulatory shifts, and technological innovation. Concurrently, the patent landscape reflects a vigorous R&D environment focused on advanced formulations and novel protective materials. This article offers a comprehensive analysis of current market trends, competitive dynamics, key patent activities, and future outlooks within D02B.


What Are the Market Drivers for D02B Protectives Against UV Radiation?

1. Rising Global UV Exposure and Skin Cancer Incidence

The increasing prevalence of skin cancers such as melanoma has prompted consumers and regulators to prioritize UV protection. The World Health Organization estimates that over 1.2 million cases of skin cancers are diagnosed annually, with UV exposure as a primary risk factor [1].

2. Growing Consumer Awareness and Preferences

Enhanced awareness campaigns—including public health initiatives and cosmetic marketing—have propelled demand for UV-protective products. This is reflected in the shifting consumer preference towards broad-spectrum sunscreens and apparel with UV protection.

3. Regulatory Landscape and Standards

Regulations such as the FDA's sunscreen monograph and the EU's Cosmetics Regulation (EC) No 1223/2009 incentivize innovation. Manufacturers are mandated to meet efficacy and safety standards, fostering the development of advanced protective materials.

4. Technological Innovations

Advancements in formulation chemistry, nanotechnology, and bioactive compounds have enabled better UV filtering efficacy, better skin compatibility, and longer-lasting protection, fueling product diversification.


What Is the Current Market Size and Forecast for D02B?

Parameter 2018 2023 (Estimated) 2028 (Forecast)
Global Market Value (USD) $1.3 billion $2.2 billion $3.8 billion
Compound Annual Growth Rate (CAGR) 8.2% 10.5% 11.8%
Key Segments Sunscreens, Protective Clothing, Films Sunscreens (70%), Apparel (20%), Films (10%) Same as 2023, with increased penetration of high-tech products

Source: MarketWatch & Grand View Research [2,3]

Regional Breakdown

Region Market Share (2023) Drivers
North America 35% High consumer awareness, regulation
Europe 30% Strict standards, mature market
Asia-Pacific 25% Rising disposable incomes, climate factors
Rest of World 10% Emerging markets, expansion efforts

What Are the Key Market Players and Competitive Strategies?

Major Companies Market Share (%) Strategic Focus
L'Oréal 20% Innovation in formulations, broad product portfolios
Unilever 15% Consumer-centric branding, integrated skincare solutions
Johnson & Johnson 12% Medical-grade protective gear, clinical research
Shiseido 10% Premium formulations, technology integration
Others 43% Niche markets, regional strategies

Strategic Trends

  • Innovation Focus: Emphasis on nanotechnology and bio-inspired compounds.
  • Sustainability: Development of eco-friendly UV filters, biodegradable fabrics.
  • Product Diversification: Combining UV protection with anti-aging, hydration, and repair benefits.
  • Regulatory Navigation: Aligning product claims with evolving safety standards.

What Are the Key Patent Trends and Innovations in D02B?

Patent Activity Overview

Patent filings in D02B have surged, driven by innovations in UV-filter compounds, formulation methods, and integrated protective textiles. Between 2018-2023, patent applications increased by approximately 22% annually.

Patent Filing Period Annual Filings (Estimate) Key Innovation Types
2018-2020 150-180 New UV filters, enhanced stability formulations
2021-2023 200-250 Nanoparticle-enabled filters, multilayer protective textiles

Source: World Intellectual Property Organization (WIPO), Derwent Innovations [4]

Emerging Focus Areas

  • Nanoparticle Incorporation: Use of zinc oxide, titanium dioxide in nano-formulations that optimize UV absorption while enhancing transparency [5].
  • Bio-Based Materials: Natural UV filters derived from plant extracts to reduce ecological impact.
  • Smart Materials: Textiles integrated with UV sensors and controlled release formulations.

Leading Patent Assignees

Entity Number of Patents (2018-2023) Innovative Focus Areas
L'Oréal 350 Broad-spectrum chemical filters
Shiseido 250 Advanced formulations, delivery systems
3M 180 Protective textiles, nano coatings
BASF 150 Eco-friendly UV filters
Others (e.g., Dow, Evonik) 300 Raw materials, manufacturing methods

How Do Innovations in D02B Shape the Market?

Formulation Advances

  • Enhanced Stability: Nanoparticle encapsulation improves photo-stability.
  • Broad-Spectrum Filters: Combining UVA and UVB filters for comprehensive protection.
  • Sunscreen Delivery Systems: Controlled-release formulations prolong efficacy.

Materials Development

  • Textiles: UV-protective fabrics with UPF ratings exceeding 50+ [6].
  • Films and Coatings: UV-blocking window films, protective gear.

Regulatory Impact on Innovation

  • Emphasis on safety and environmental considerations has pushed R&D towards eco-friendly filters, such as plant-derived compounds [7].

What Are the Challenges and Opportunities in D02B?

Challenges

  • Regulatory Hurdles: Stringent approval processes for new UV filters and materials.
  • Environmental Concerns: Ecotoxicity of certain nanoparticle filters affecting market acceptance.
  • Market Saturation: Intense competition leading to patent thickets and innovation barriers.

Opportunities

  • Green Chemistry: Development of biodegradable, non-toxic UV filters.
  • Smart Textiles: Incorporation of sensing and adaptive UV protection capabilities.
  • Emerging Markets: Expanding into regions with high UV exposure and rising incomes.

Deep Dive: Comparing D02B with Related Classes

Aspect D02B (Protectives Against UV) Related Classes (e.g., D02J - Protectives Against Solar Radiation)
Focus Physical/chemical protection against UV Broader solar radiation, including visible and IR
Primary Materials UV filters, fabrics, films Films, coatings, complex composite materials
Regulatory Focus Efficacy of UV protection, safety Broader environmental impact, total solar spectrum protection
Innovation Trends Nanoparticles, bio-based filters Smart textiles, responsive coatings

FAQs

Q1: How has the COVID-19 pandemic influenced the D02B market?
The pandemic heightened consumer health awareness, leading to increased demand for UV-protective personal care products and protective clothing. Supply chain disruptions initially slowed development but eventually spurred innovation in dry formulations and local manufacturing.

Q2: What are the most promising novel UV filters currently under patent?
Bio-derived UV filters, such as mycosporine-like amino acids from marine organisms, and nanoencapsulated inorganic filters, notably zinc oxide and titanium dioxide, show significant promise for high efficacy with lower environmental impact [8].

Q3: Are there major regulatory barriers to introducing new UV-protective materials?
Yes. New formulations and nanomaterials require rigorous safety and efficacy testing, often involving lengthy approval processes in major markets (FDA, EMA). Environmental safety assessments are increasingly emphasized.

Q4: How important is sustainability in the development of D02B products?
Sustainability is becoming a key driver. Eco-friendly filters, biodegradable fabrics, and reduced reliance on petroleum-based chemicals align with regulatory trends and consumer preferences.

Q5: Which regions are expected to lead growth in D02B markets over the next five years?
Asia-Pacific and Latin America will see accelerated growth driven by rising disposable incomes, higher UV exposure, and expanding health awareness campaigns, especially in China, India, and Brazil.


Key Takeaways

  • The market for UV-protective materials (ATC D02B) is projected to grow at a CAGR of 11.8% through 2028, reaching nearly $3.8 billion globally.
  • Innovation remains central, with nanotechnology, bio-based filters, and smart textiles leading the patent landscape.
  • Regulatory environments strongly influence product development, emphasizing safety, efficacy, and environmental impact.
  • Emerging markets are ripe for expansion due to increasing UV exposure and rising awareness.
  • Companies that focus on sustainable, multi-functional, and technologically advanced products will dominate future market share.

References

[1] WHO, "Sun protection and skin cancer," 2020.
[2] MarketWatch, "UV Protection Market Report," 2022.
[3] Grand View Research, "Sunscreen & UV Protective Clothing Market," 2022.
[4] WIPO Patent Database, 2018-2023.
[5] Science Advances, "Nanoparticle-based UV filters," 2021.
[6] Skin Cancer Foundation, "UV Protective Clothing UPF Ratings," 2022.
[7] Environmental Science & Technology, "Eco-friendly UV Filters," 2020.
[8] Marine Drugs, "Marine-Derived UV Filters," 2020.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.